Pharmaceutical & Biotech
Mexico Registers US$2 Billion in Pharmaceutical Investments
The Secretary of Economy of Mexico announced a series of investments by private companies, including more than US$2 billion for the pharmaceuticals industry
Released Thursday, March 28, 2024
Reports related to this article:
Project(s): View 6 related projects in PECWeb
Plant(s): View 6 related plants in PECWeb
Researched by Industrial Info Resources (Sugar Land, Texas)--The Secretary of Economy of Mexico recently announced a series of investments by private companies within numerous industrial sectors in the country, including the pharmaceuticals industry, where more than US$2 billion in investments has been identified.
By state, the State of Mexico has more than 22% of the investments, or US$475 million. Nuevo Leon follows with nearly 20% in investments, or US$416 million; Queretaro has nearly 16% of the investments, or more than US$340 million; and Mexico City has more than 9% of the total investments, or more than US$199 million. Project investments in Baja California del Norte and Hidalgo are also outstanding, with more than 7% or US$155 million, and 7% or more than US$151 million, respectively.
In the State of Mexico, the most significant investment is the Sanofi vaccine plant in Cuatitlan Izacalli, for more than US$150 million. The French company expects to complete the construction of the vaccine plant in the second quarter of this year. In Nuevo León, Unilever plans to begin construction of a US$400 million grassroot beauty and personal care products plant in the second quarter of this year as well.
In Queretaro, Abbott is investing US$150 million in a new catheter plant currently under construction with completion by mid-2025.
Mexico City stands out with Organon's investment of more than US$48 million, to be implemented in Xochimilco as part of an expansion that the North American company plans to implement in the second quarter of 2024.
In addition, Harmac Medical in Baja California del Norte is investing US$50 million for a new contract development and manufacturing organization (CDMO) plant for single-use medical devices, with a completion date in second-quarter 2024. Finally, Productos Científicos, of Carnot Laboratorios, is expected to complete a new solid pharmaceutical forms plant in Villa de Tezontepec, in Hidalgo, with an investment of more than US$100 million.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 Trillion (USD).
/news/article.jsp
false
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
U.S. Supplement Production Brings Millions in SpendingApril 29, 2024
-
A Glossy Future for Cosmetics: Global Personal Care Market o...November 17, 2023
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
2026 European Petroleum Refining Project OutlookPodcast Episode / Jun 26, 2026
-
Brazil: Efficiency, Innovation, and Opportunities in the Food & Beverage IndustryPodcast Episode / Jun 12, 2026
-
2026-2027 Investment Radar for Mexico, Central America & the CaribbeanPodcast Episode / May 29, 2026
-
Innovations Shaping the Next Era of Power GenerationPodcast Episode / May 22, 2026
-
The Role of Contract Manufacturing in Global Pharma GrowthPodcast Episode / May 8, 2026